Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Group B streptococcal vaccines.

C J Baker, D L Kasper

    Reviews of Infectious Diseases
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Group B Streptococcus (GBS) vaccines using purified polysaccharides show promise for preventing infant infections. Immunization of pregnant women could transfer protective antibodies, reducing neonatal GBS disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Four ppm measurement of the antihydrogen ground-state hyperfine splitting.

    Nature·2026
    Same author

    Be<sup>+</sup> assisted, simultaneous confinement of more than 15000 antihydrogen atoms.

    Nature communications·2025
    Same author

    Rotational orientation control of a ground state ortho-H<sub>2</sub> dissociation on a metal surface.

    Nature communications·2025
    Same author

    Observation of the effect of gravity on the motion of antimatter.

    Nature·2023
    Same author

    Human Echolocators Have Better Localization Off Axis.

    Psychological science·2022
    Same author

    Sympathetic cooling of positrons to cryogenic temperatures for antihydrogen production.

    Nature communications·2021
    Same journal

    Fatal necrotizing otitis externa in a patient with AIDS.

    Reviews of infectious diseases·1991
    Same journal

    Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces.

    Reviews of infectious diseases·1991
    Same journal

    A new case of meningitis due to Pasteurella multocida.

    Reviews of infectious diseases·1991
    Same journal

    Disseminated pelvic actinomycosis presenting as metastatic carcinoma: association with the progestasert intrauterine device.

    Reviews of infectious diseases·1991
    Same journal

    Genetically engineered attenuated herpes simplex viruses.

    Reviews of infectious diseases·1991
    Same journal

    Role of altered drug metabolism in virus-drug interactions.

    Reviews of infectious diseases·1991
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Infectious Diseases
    • Vaccinology

    Background:

    • Group B Streptococcus (GBS) is a significant perinatal pathogen.
    • Infant susceptibility to GBS infection is linked to maternal antibody deficiency.
    • Vaccination strategies aim to induce protective antibodies via maternal immunization.

    Purpose of the Study:

    • To evaluate the safety and immunogenicity of purified GBS type-specific polysaccharides as candidate vaccines.
    • To assess the potential for placental transfer of vaccine-induced antibodies for infant protection.

    Main Methods:

    • Purification and characterization of native GBS type Ia, II, and III polysaccharides.
    • Administration of polysaccharides as immunogens to healthy adult volunteers.
    • Measurement of antibody responses, including isotype and functional activity (opsonophagocytosis).

    Related Experiment Videos

    Main Results:

    • Native GBS polysaccharides were safe and non-toxic in adults.
    • Immunogenicity varied by serotype: Type Ia (65%), Type II (95%), Type III (70%) in non-immune adults.
    • Antibody responses were near 100% in previously immune volunteers.
    • Vaccine-induced antibodies demonstrated in vitro opsonophagocytosis and in vivo protection in animal models.

    Conclusions:

    • Purified GBS polysaccharides are safe and immunogenic candidate vaccines.
    • Further studies in pregnant women are needed to confirm efficacy in preventing neonatal GBS disease.